Related Experiment Videos

A Raf-1-related p110 polypeptide associates with the CD4-p56lck complex in T cells

K V Prasad1, C E Rudd

  • 1Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Insights

A novel 110-kDa protein (p110) associates with the CD4-p56lck complex in T cells, potentially bridging it to Raf-1 kinase pathways. This finding offers new insights into T-cell activation signaling.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • T cell receptor complexes, including CD4 and CD8, interact with intracellular mediators like p56lck and p32.
  • Understanding these interactions is crucial for elucidating downstream signaling pathways.

Purpose of the Study:

  • To identify novel polypeptides associated with the CD4-p56lck complex in human T lymphocytes.
  • To investigate the nature and function of a newly detected 110-kDa polypeptide (p110).

Main Methods:

  • Co-immunoprecipitation assays using human peripheral blood T lymphocytes and T-cell lines.
  • Western blot analysis with specific antisera, including one against Raf-1 kinase.
  • Analysis of p110 phosphorylation and its association with CD4-p56lck upon phorbol ester treatment.

Main Results:

  • A 110-kDa polypeptide (p110) was detected associated with the CD4-p56lck complex.
  • p110 preferentially bound to the assembled CD4-p56lck complex, not individual components.
  • p110 is related to Raf-1 kinase and phosphorylated on serine residues.
  • Phorbol ester treatment increased p110 association with CD4-p56lck and modulated CD4-p56lck surface expression.

Conclusions:

  • The Raf-1-related p110 is a novel component of the CD4-p56lck signaling complex.
  • p110 likely plays a role in signal transduction from the CD4-p56lck complex.
  • p110 may act as a molecular bridge connecting the CD4-p56lck complex to serine/threonine kinase pathways involved in T-cell activation.

Related Concept Videos